Core Viewpoint - A class action securities lawsuit has been filed against Avantor, Inc. alleging securities fraud that negatively impacted investors between March 5, 2024, and October 28, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Avantor's competitive positioning was misrepresented, indicating it was weaker than publicly stated [2]. - It is alleged that Avantor faced negative impacts from increased competition, which were not disclosed by the defendants [2]. - The representations made by the defendants regarding the company's business, operations, and prospects are claimed to be materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 29, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the U.S. [4].

NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Stride, Inc. ("Stride" or the "Company") (NYSE: LRN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Stride investors who were adversely affected by alleged securities fraud between October 22, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/stride-inc-lawsuit-submission-form ...

Core Viewpoint - A class action securities lawsuit has been filed against James Hardie Industries plc, alleging securities fraud that negatively impacted investors between May 20, 2025, and August 18, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that James Hardie Industries made false statements and concealed adverse facts regarding its North America segment, including deteriorating consumer demand and growth [2]. - It is alleged that overstocking was the main driver of growth in the North America segment during the class period, rather than genuine consumer demand, leading to excessive inventory at distributors [2]. Group 2: Investor Information - Investors who suffered losses during the specified time frame have until December 23, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Skye Bioscience, Inc. due to alleged securities fraud affecting investors between November 4, 2024, and October 3, 2025 [1][2]. Group 1: Lawsuit Details - The complaint alleges that the company's lead product candidate, nimacimab, was less effective than previously claimed, leading to overstated clinical, regulatory, and commercial prospects [2]. - Defendants' public statements regarding nimacimab were materially false and misleading throughout the relevant period [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Legal Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Integer Holdings Corporation, alleging securities fraud that adversely affected investors between July 25, 2024, and October 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Integer Holdings materially overstated its competitive position in the electrophysiology manufacturing market [2]. - It is alleged that despite claims of strong visibility into customer demand, the company was experiencing a sustained decline in sales related to two of its electrophysiology devices [2]. - The complaint further asserts that Integer mischaracterized its electrophysiology devices as a long-term growth driver for its cardio & vascular segment [2]. - As a result of these issues, the positive statements made by the defendants regarding the company's business and prospects were deemed materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until February 9, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against Freeport-McMoRan Inc. alleging securities fraud that affected investors between February 15, 2022, and September 24, 2025 [1][2]. Group 1: Allegations - The lawsuit claims that Freeport-McMoRan did not ensure adequate safety at the Grasberg Block Cave mine in Indonesia [2]. - It is alleged that the lack of proper safety measures posed a heightened risk that could foreseeably lead to worker fatalities [2]. - The complaint states that this situation created undisclosed risks related to regulatory, litigation, and reputational issues [2]. - As a result, statements made by the defendants regarding Freeport-McMoRan's business, operations, and prospects were materially false and misleading [2]. Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until January 12, 2026, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff to share in any potential recovery [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against CarMax, Inc. alleging securities fraud that affected investors between June 20, 2025, and November 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false statements and concealed information regarding CarMax's growth prospects, suggesting that the growth was temporary and driven by speculation about tariffs [2]. - It is alleged that the statements made by the defendants about CarMax's business operations and prospects were materially false and misleading [2]. Group 2: Investor Information - Investors who suffered losses during the specified time frame have until January 2, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against Inspire Medical Systems, Inc. due to alleged securities fraud affecting investors between August 6, 2024, and August 4, 2025 [1]. Group 1: Lawsuit Details - The lawsuit claims that the launch of Inspire Medical Systems' new product, Inspire V, was unsuccessful due to poor demand and excess inventory at treatment centers, contradicting prior assurances from the company [2]. - Allegations include that Inspire Medical Systems failed to complete essential tasks for the product launch, such as training for treatment center customers, setting up IT systems, and ensuring proper Medicare reimbursement [2]. Group 2: Next Steps for Investors - Investors who experienced losses during the specified timeframe have until January 5, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be eligible for compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A securities class action lawsuit has been filed against Firefly Aerospace Inc. for allegedly making false and misleading statements regarding its business operations and growth prospects during its IPO and subsequent period [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Firefly common stock during the IPO on August 7, 2025, and securities between August 7, 2025, and September 29, 2025 [1]. - The lead plaintiff deadline for the lawsuit is set for January 12, 2026 [1]. Group 2: Allegations Against Defendants - The complaint alleges that Firefly overstated the demand and growth prospects for its Spacecraft Solutions offerings [2]. - It is claimed that the Alpha rocket program did not meet its operational readiness and commercial viability as represented [2]. - As a result of these issues, the statements made by the defendants regarding the company's business and prospects were materially false and misleading [2]. Group 3: Lead Plaintiff Process - Investors may seek to be appointed as a lead plaintiff representative of the class by the January 12, 2026 deadline, or they can choose to remain absent class members [3]. - The lead plaintiff will act on behalf of all class members and select counsel to represent the class [3]. Group 4: Law Firm Background - Kessler Topaz Meltzer & Check, LLP is a prominent U.S. law firm specializing in securities-fraud class actions and investor protection [4]. - The firm has a history of leading significant recoveries in securities litigation and has received multiple accolades for its work [4].

Core Viewpoint - The Law Offices of Frank R. Cruz is investigating Above Food Ingredients Inc. for potential violations of federal securities laws, indicating concerns regarding the company's compliance and financial practices [1]. Group 1 - The investigation is initiated on behalf of investors who may have suffered financial losses related to Above Food Ingredients Inc. [1] - The company disclosed information on December 2, 2025, which is central to the investigation [1].